Form D — Conceivable Life Sciences Inc.
0001013594-25-001151 · filed Sep 15, 2025
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Check this disclosure on SEC EDGAR · More Other Health Care filings
Offering
- Industry
- Other Health Care
- Exemptions
- Rule 506(b)
- Reported offering amount
- $33,000,000
- Reported amount sold
- $30,499,997
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Conceivable Life Sciences Inc.
- CIK
- 1986248
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2022
- Address
- 160 MERCER STREET
NEW YORK, New York 10012 - Phone
- 917-657-2175
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Alan Murray · Executive OfficerNew York, New York Find on LinkedIn ↗
-
Alejandro Chavez-Badiola · Executive OfficerMexico City, Mexico Find on LinkedIn ↗
-
Aike Ho · DirectorSan Francisco, California Find on LinkedIn ↗
-
Fred Destin · DirectorLondon, United Kingdom Find on LinkedIn ↗
-
Stuart Peterson · DirectorSan Francisco, California Find on LinkedIn ↗
-
Alex Christ · DirectorNew York, New York Find on LinkedIn ↗
Other filings from this issuer
View the original filing on SEC EDGAR ↗